The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 26, 2020

Filed:

Sep. 04, 2015
Applicant:

Kuhs Gmbh, Loerrach, DE;

Inventor:

Martin Albrecht, Odenthal, DE;

Assignee:

Kuhs GmbH, Loerrach, DE;

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 8/14 (2006.01); A61K 8/34 (2006.01); A61K 8/35 (2006.01); A61K 8/40 (2006.01); A61K 8/42 (2006.01); A61K 8/49 (2006.01); A61K 8/55 (2006.01); A61K 8/64 (2006.01); A61K 8/67 (2006.01); A61K 8/92 (2006.01); A61K 8/97 (2017.01); A61K 9/00 (2006.01); A61K 47/24 (2006.01); A61K 47/44 (2017.01); A61Q 17/04 (2006.01); A61Q 19/00 (2006.01);
U.S. Cl.
CPC ...
A61K 8/14 (2013.01); A61K 8/345 (2013.01); A61K 8/35 (2013.01); A61K 8/40 (2013.01); A61K 8/42 (2013.01); A61K 8/553 (2013.01); A61K 8/671 (2013.01); A61K 8/922 (2013.01); A61Q 17/04 (2013.01); A61Q 19/00 (2013.01);
Abstract

A cosmetic or pharmaceutical composition, to be applied topically is described, which has a hydrophilic outer phase, at least one cosmetic and/or pharmaceutical active ingredient and at least one carrier substance for the active ingredient. The carrier substance here forms such structures, which comprises at least two lamellar double membrane layers arranged one over another in the manner of a sandwich, wherein between adjacent double membrane layers, aligned parallel to each other, a layer of an inner phase is respectively arranged. The active ingredient is distributed in the double membrane layer and in the layer of the inner phase such that the layer of the inner phase contains the active ingredient in a concentration range between 2% by weight and 98% by weight and the double membrane layer contains the active ingredient in a concentration between 98% by weight and 2% by weight, respectively in relation to the total concentration of active ingredient, and the outer phase has no or almost no active ingredient.


Find Patent Forward Citations

Loading…